October 10, 2017
London-based medical device manufacturer LivaNova has announced FDA approval of its most recent Vagus Nerve Stimulation Therapy (VNS Therapy) System, which will be the smallest and lightest responsive therapy available for drug-resistant epilepsy patients aged four years and older.
The treatment consists of the new SenTiva implantable generator, the VNS Therapy Programming System, a wireless wand...
August 17, 2017
UCB, a global pharmaceutical company, is partnering with Belgian American health startup Byteflies to use the startup's wearable sensors to monitor seizures.
Byteflies makes a customizable wearable device for the pharma and healthcare industries called Sensor Dot. It's a quarter-sized sensor that can be worn around the wrist or attached anywhere on the body as a patch. It's capable of measuring ...
December 5, 2016
Marlborough, Massachusetts-based pharma company Sunovion will use the Empatica Embrace, a wearable device for seizure detection, in a phase 4 clinical study of Aptiom, a drug meant to reduce seizures in people with epilepsy.
“We believe that incorporating digital health technologies into traditional treatment paradigms has the potential to inform and enhance best practices and further empower...
November 2, 2015
One of the great but nebulous promises of wearable health trackers is that, by monitoring something 24-7 that previously was only ever monitored intermittently, it will help us discover new things about our bodies and health. MIT Professor and Empatica Chief Scientist Rosalind Picard can do one better -- a wearable device she designed helped her to make an accidental discovery that could change...